We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
AUM
$2.02B
AUM Growth
-$610M
Cap. Flow
-$464M
Cap. Flow %
-22.96%
Top 10 Hldgs %
15.91%
Holding
593
New
137
Increased
10
Reduced
43
Closed
147

Top Buys

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$72M
2
BX icon
Blackstone
BX
+$33.3M
3
CLOV icon
Clover Health Investments
CLOV
+$32.5M
4
ACI icon
Albertsons Companies
ACI
+$31.7M
5
WB icon
Weibo
WB
+$28.4M

Top Sells

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$105M
2
CLVT icon
Clarivate
CLVT
+$58.9M
3
OPEN icon
Opendoor
OPEN
+$57.5M
4
VICI icon
VICI Properties
VICI
+$56.8M
5
EQT icon
EQT Corp
EQT
+$51.1M

Sector Composition

Rank Sector Weight
1 Financials 29.7%
2 Technology 26.65%
3 Consumer Discretionary 15.3%
4 Healthcare 7.21%
5 Industrials 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQT icon
476
EQT Corp
EQT
$34B
-2,500,000
Closed -$51.1M
ESTC icon
477
Elastic
ESTC
$7.94B
-12,500
Closed -$1.86M
FTAI icon
478
FTAI Aviation
FTAI
$23.2B
-146,375
Closed -$3.17M
GILT icon
479
Gilat Satellite Networks
GILT
$846M
-975,410
Closed -$8.77M
GLUE icon
480
Monte Rosa Therapeutics
GLUE
$1.34B
-15,000
Closed -$334K
GSL icon
481
Global Ship Lease
GSL
$1.47B
-20,000
Closed -$474K
HEPS
482
D-Market Electronic Services & Trading
HEPS
$1.04B
-750,000
Closed -$5.14M
NBP
483
NovaBridge Biosciences American Depositary Shares
NBP
$213M
-37,500
Closed -$2.72M
IMRX icon
484
Immuneering
IMRX
$311M
-15,000
Closed -$398K
INGN icon
485
Inogen
INGN
$157M
-98,636
Closed -$4.25M
INSM icon
486
Insmed
INSM
$29B
-20,000
Closed -$551K
INVH icon
487
Invitation Homes
INVH
$17.7B
-550,000
Closed -$21.1M
IONQ icon
488
IonQ
IONQ
$17.6B
-164,000
Closed -$1.71M
IPSC icon
489
Century Therapeutics
IPSC
$372M
-15,000
Closed -$377K
IVR icon
490
Invesco Mortgage Capital
IVR
$802M
-2,000
Closed -$63K
IVVD icon
491
Invivyd
IVVD
$203M
-40,000
Closed -$1.69M
LOCL icon
492
Local Bounti
LOCL
$28.7M
-11,538
Closed -$1.49M
LYEL icon
493
Lyell Immunopharma
LYEL
$365M
-750
Closed -$222K
MAXN
494
DELISTED
Maxeon Solar Technologies
MAXN
-200
Closed -$353K
MCB icon
495
Metropolitan Bank Holding Corp
MCB
$1.15B
-5,000
Closed -$422K
MGY icon
496
Magnolia Oil & Gas
MGY
$6.16B
-800,000
Closed -$14.2M
CALY
497
Callaway Golf Company
CALY
$3.01B
-35,000
Closed -$967K
MP icon
498
MP Materials
MP
$9.84B
-75,000
Closed -$2.42M
MTLS
499
Materialise
MTLS
$398M
-20,000
Closed -$402K
NPCE icon
500
Neuropace
NPCE
$513M
-15,000
Closed -$238K

Similar funds

Ghisallo Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Ghisallo Capital Management held 593 positions worth $2.02B, down 23% from $2.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ghisallo Capital Management withdrew a net $464M in Q4 2021, closing 147 positions and reducing 43 holdings. Its most notable exit was Coupang, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Ghisallo Capital Management opened a new position in Rivian worth $64.8M.

  • Ghisallo Capital Management's largest Q4 2021 buy was Rivian: 625,000 shares worth $64.8M.
  • Ghisallo Capital Management added most to Snowflake in Q4 2021, an estimated $17.4M increase.
  • Ghisallo Capital Management's biggest Q4 2021 reduction was Sea Limited, cutting an estimated $50.7M.
  • Ghisallo Capital Management fully exited Coupang in Q4 2021, selling an estimated $105M.
  • Ghisallo Capital Management's ten largest holdings make up 16% of its $2.02B portfolio in Q4 2021.
  • Ghisallo Capital Management opened 137 new positions and closed 147 in Q4 2021.
  • Ghisallo Capital Management's portfolio value fell 23% quarter-over-quarter to $2.02B.

Based on Ghisallo Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.